Despite the best antibiotics and intensive care, sepsis is the primary cause of death from infection. And sepsis cases are increasing, up by between 8% and 13% over the last decade, claiming more lives than bowel and breast cancer combined.
Sepsis: Increasingly COMMON,
OFTEN FATAL, AND ALWAYS COSTLY
Sepsis cases a year
in the US alone
costs a year
Source: HCUP Statistical Brief #204 (May 2016)
It usually takes between 2 and 6 days to diagnose blood infections using a blood culture, depending whether the microbe is bacterial or fungal. While organisms culture in the laboratory, treatment remains empirical.
The LiDiaTM Bloodstream Infection (BSI) test takes about 3 hours to complete and an actionable result is delivered in time to the effectiveness of treatment.
DELIVERED TO THE
CLINICIAN IN 3 HOURS
Urgent need: Mortality increases 7.6+% for every hour after onset of hypotension. Kumar et al. (2006) Critical Care Med.
Focused and fast
Dialog with over 100 practising clinicians and lab directors has confirmed the potential value and impact of LiDia: making it quick and simple to get patients with suspected bloodstream infection treated with the best therapy.
The LiDia bloodstream infection test will analyze a blood sample directly from an uncultured specimen. This is a breakthrough: one test is enough to identify a broad range of possible bloodstream infectious organisms, as well as a selection of antimicrobial resistance genes. Because microbial pathogens in blood infections may be present at very low concentrations (1 colony-forming unit per ml), LiDia for bloodstream infection incorporates a sample preparation stage capable of extracting microbial DNA from a vacutainer of blood, which is subsequently amplified and identified.
A rapid and sensitive ID test has impact on therapy when used on patients in the sepsis cascade and even at the late stage
DNAe Group Holdings Ltd
Ugli Campus Block C
56 Wood Lane
DNA Electronics, Inc.
1891 Rutherford Road
Carlsbad, CA 92008
+1 (760) 444-9410
KEEP IN TOUCH